rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-5-16
|
pubmed:abstractText |
We report a study of induction chemotherapy followed by concurrent chemoradiotherapy for stage IIIA/IIIB non-small cell lung cancer.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1444-0903
|
pubmed:author |
pubmed-author:BuckMM,
pubmed-author:ByrneM JMJ,
pubmed-author:CameronFF,
pubmed-author:De MelkerYY,
pubmed-author:DewarJJ,
pubmed-author:JosephDD,
pubmed-author:LundHH,
pubmed-author:NewmanMM,
pubmed-author:PhillipsMM,
pubmed-author:PowellAA,
pubmed-author:TRUCFF,
pubmed-author:Van HazelGG
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
336-42
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:15892762-Adult,
pubmed-meshheading:15892762-Aged,
pubmed-meshheading:15892762-Antimetabolites, Antineoplastic,
pubmed-meshheading:15892762-Antineoplastic Agents,
pubmed-meshheading:15892762-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15892762-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15892762-Cisplatin,
pubmed-meshheading:15892762-Combined Modality Therapy,
pubmed-meshheading:15892762-Deoxycytidine,
pubmed-meshheading:15892762-Female,
pubmed-meshheading:15892762-Fluorouracil,
pubmed-meshheading:15892762-Humans,
pubmed-meshheading:15892762-Lung Neoplasms,
pubmed-meshheading:15892762-Male,
pubmed-meshheading:15892762-Middle Aged,
pubmed-meshheading:15892762-Radiotherapy Dosage
|
pubmed:year |
2005
|
pubmed:articleTitle |
Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancer.
|
pubmed:affiliation |
Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia. mjbyrne@cyllene.uwa.edu.au
|
pubmed:publicationType |
Journal Article
|